ER-BED: Deficits in Emotion Regulation Skills as a Maintaining Factor in Binge Eating Disorder

Sponsor
Friedrich-Alexander-Universität Erlangen-Nürnberg (Other)
Overall Status
Completed
CT.gov ID
NCT03717493
Collaborator
German Research Foundation (Other), University of Freiburg (Other), University Hospital Tuebingen (Other)
99
2
58.5

Study Details

Study Description

Brief Summary

The effectiveness of a systematic affect regulation training (ART; Berking, 2010) is evaluated with regard to reducing symptoms of binge eating disoder in a randomized controlled trial.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Affect Regulation Training
Phase 2/Phase 3

Detailed Description

Evidence suggests that deficits in affect regulation play an important role in the development and maintenance of binge eating disorder (BED). Thus, we aim to clarify whether BED symptoms can be reduced with the help of a training of general affect regulation skills. For this purpose, we randomly allocated N = 99 individuals meeting criteria for BED either to an affect regulation training (ART) or to a wait list control condition (WLC). Primary outcome is the reduction of binges during the treatment-vs.-waiting period as assessed with the Eating Disorder Examination (EDE) interview. Secondary outcomes include BED symptom severity at follow-up and change in emotion regulation skills. To clarify whether potential differences between groups regarding change in binge eating result from a greater increase of affect regulation skills in ART, we will test whether potential group differences regarding binges will be mediated by differences between groups regarding change in affect regulation skills.

Change of randomization procedure: Over the course of the study, serious difficulties occurred with regard to recruiting participants as quickly as necessary to avoid drop-outs due to participants' unwillingness to wait until eight individuals were recruited for randomization. To solve the problem, we switched from the original block randomization to a procedure in which the next patient eligible for the study was allocated to the treatment condition until the minimum group size of four was reached.

Study Design

Study Type:
Interventional
Actual Enrollment :
99 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Intervention Model Description:
Randomized controlled trial; group x timeRandomized controlled trial; group x time
Masking:
Single (Outcomes Assessor)
Masking Description:
Assessors were blinded with regard to study condition
Primary Purpose:
Treatment
Official Title:
Deficits in Emotion Regulation Skills as a Maintaining Factor in Binge Eating Disorder
Actual Study Start Date :
Dec 17, 2012
Actual Primary Completion Date :
May 1, 2017
Actual Study Completion Date :
Nov 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Affect Regulation Training (ART)

Affect Regulation Training (ART; Berking & Whitley, 2014) is a transdiagnostic, group-based intervention aiming to enhance general affect regulation skills in individuals who meet criteria for mental disorders or are at-risk of developing mental-health problems.

Behavioral: Affect Regulation Training
Following the guidelines for the 6-week intensive ART format, we scheduled one 180-minutes session per week (each consisting of two modules à 90min) for a period of six subsequent weeks. Training groups included four to eight participants. The implementation of ART followed standardized treatment protocols (Berking & Whitley, 2014). ART was delivered by doctoral candidates (DCs) in clinical psychology who had completed or were in advanced stages of their clinical training. All therapists had been intensely trained and received weekly supervision from experienced ART trainers. To control adherence a random sample of 5% of all sessions was be videotaped and will be rated with regard to adherence.

No Intervention: Waitlist Control Condition (WLC)

In order to control for the effects of time, we compared changes during ART with changes during WLC. Participants in the WLC condition received no treatment within the study but were offered to participate in ART after completing all assessments.

Outcome Measures

Primary Outcome Measures

  1. Number of binges [past 28 days]

    Number of binges as assessed in the Eating Disorder Examination Interview (EDE; Fairburn & Cooper, 1993; German version: Hilbert & Tuschen-Caffier, 2006)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 69 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • diagnosis of BED according to DSM-5 criteria

  • age over 18 and below 69

  • 25 < BMI < 45

  • ability and willingness to provide informed consent

Exclusion Criteria:
  • high risk of suicide

  • co-occurring psychotic, bipolar disorders, alcohol/substance dependence within the past six months and/or borderline personality disorder

  • medical disorders that would affect weight and/or the ability to participate

  • insufficient German language skills (as assessments and treatment were conducted in German)

  • current participation in psychotherapeutic treatment other than those offered in the study

  • current participation in a weight control program

  • taking medication that would affect weight

  • pregnancy.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Friedrich-Alexander-Universität Erlangen-Nürnberg
  • German Research Foundation
  • University of Freiburg
  • University Hospital Tuebingen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Matthias Berking, Ph.D., Head of department of clinical psychology, principle investigator, University of Erlangen-Nürnberg
ClinicalTrials.gov Identifier:
NCT03717493
Other Study ID Numbers:
  • BE4510/1-5
First Posted:
Oct 24, 2018
Last Update Posted:
Aug 28, 2020
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Matthias Berking, Ph.D., Head of department of clinical psychology, principle investigator, University of Erlangen-Nürnberg
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 28, 2020